David Abrams - Abrams Capital Management,
Holding/activity history for Keryx Biopharmaceuticals Inc (KERX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q4 | 0 | 0.00 | Sell 100.00% | 0.82 | SEC | ||
| 2018 Q3 | 9,108,867 | 0.82 | Reduce 8.45% | 0.09 | $3.40 | $30,970,000 | SEC |
| 2018 Q2 | 9,950,055 | 1.04 | Add 2.38% | 0.02 | $3.76 | $37,412,000 | SEC |
| 2018 Q1 | 9,719,176 | 1.25 | $4.09 | $39,751,000 | SEC | ||
| 2017 Q4 | 9,719,176 | 1.52 | Add 69.94% | 0.63 | $4.65 | $45,194,000 | SEC |
| 2017 Q3 | 5,719,176 | 1.58 | $7.10 | $40,606,000 | SEC | ||
| 2017 Q2 | 5,719,176 | 1.64 | $7.23 | $41,350,000 | SEC | ||
| 2017 Q1 | 5,719,176 | 1.35 | $6.16 | $35,230,000 | SEC | ||
| 2016 Q4 | 5,719,176 | 1.34 | $5.86 | $33,514,000 | SEC | ||
| 2016 Q3 | 5,719,176 | 1.66 | $5.31 | $30,369,000 | SEC | ||
| 2016 Q2 | 5,719,176 | 2.21 | $6.62 | $37,861,000 | SEC | ||
| 2016 Q1 | 5,719,176 | 1.37 | Add 3.99% | 0.05 | $4.67 | $26,709,000 | SEC |
| 2015 Q4 | 5,500,000 | 1.62 | Add 10.00% | 0.15 | $5.05 | $27,775,000 | SEC |
| 2015 Q3 | 5,000,000 | 1.33 | Buy | 1.33 | $3.52 | $17,600,000 | SEC |